CoChat

A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease.

Barrett-Connor, Elizabeth, Khaw, Kay-Tee, Yen, Samuel S.C. · 1986 · New England Journal of Medicine

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

It has been postulated that dehydroepiandrosterone (DHEA) and its sulfate ester, dehydroepiandrosterone sulfate (DHEAS), the major secretory products of the human adrenal gland, may be discriminators of life expectancy and aging. We examined the relation of base-line circulating DHEAS levels to subsequent 12-year mortality from any cause, from cardiovascular disease, and from ischemic heart disease in a population-based cohort of 242 men aged 50 to 79 years at the start of the study. Mean DHEAS levels decreased with age and were also significantly lower in men with a history of heart disease than in those without such a history. In men with no history of heart disease at base line, the age-adjusted relative risk associated with a DHEAS level below 140 micrograms per deciliter was 1.5 (P not significant) for death from any causes, 3.3 (P less than 0.05) for death from cardiovascular disease, and 3.2 (P less than 0.05) for death from ischemic heart disease. In multivariate analyses, an increase in DHEAS level of 100 micrograms per deciliter was associated with a 36 percent reduction in mortality from any causes (P less than 0.05) and a 48 percent reduction in mortality from cardiovascular disease (P less than 0.05), after adjustment for age, systolic blood pressure, serum cholesterol level, obesity, fasting plasma glucose level, cigarette smoking status, and personal history of heart disease. Our conclusions are limited by the single determination of DHEAS levels, but the data suggest that the DHEAS concentration is independently and inversely related to death from any cause and death from cardiovascular disease in men over age 50.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm198612113152405

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Research works printed but not linked: 7

  1. Vermeulen A. Adrenal androgens and aging. In: Genazzani AR, Thijssen JHH, Siiteri PK, eds. Adrenal androgens. New York: Raven Press, 1980:207–17.
  2. Lopez-S A. Metabolic and endocrine factors in aging. In: Rothschild H, Chapman CF, eds. Risk factors for senility. New York: Oxford University Press, 1984:205–19.
  3. Marmorston, 1957, Geriatrics, 12, 297
  4. Mantel, 1959, JNCI, 22, 719
  5. Šonka, 1964, J Physiol (Lond), 56, 650
  6. Schwartz, 1979, Cancer Res, 39, 1129
  7. Schwartz, 1985, Basic Life Sci, 35, 181

Cited by

See all 681

Metadata

Authors
Barrett-Connor, E., Khaw, K.-T., & Yen, S. S. C.
Venue
New England Journal of Medicine
Published
1986-12-11
Volume
315
Issue
24
Pages
1519-1524
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2034566257
Cited by
681
References
36
Citations by year
2025: 4 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 8 · 2017: 6 · 2016: 6 · 2015: 15 · 2014: 9 · 2013: 16 · 2012: 20
FWCI
11.60
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01am031801-03)
  • National Heart, Lung, and Blood Institute (HL 34591, HV-1-2160-L)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
dehydroepiandrosterone sulfate, mortality, cardiovascular disease, ischemic heart disease, aging, adrenal hormones, circulating hormone levels, men, life expectancy
MeSH terms
Aged, Aging, Analysis of Variance, Cardiovascular Diseases, Coronary Disease, Dehydroepiandrosterone, Humans, Life Expectancy, Male, Middle Aged, Mortality, Prospective Studies, Smoking, Dehydroepiandrosterone Sulfate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. https://app.cochat.ai/papers/10.1056/nejm198612113152405
The paper
Barrett-Connor, E., Khaw, K.-T., & Yen, S. S. C. (1986). A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. New England Journal of Medicine. https://doi.org/10.1056/nejm198612113152405

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.